Health Canada approves REBINYN® (Coagulation Factor IX (Recombinant), pegylated) for the treatment of routine prophylaxis to prevent or reduce frequency of bleeding episodes in children with hemophilia B
/CNW/ - Novo Nordisk announced today that Health Canada has approved a new indication for REBINYN® (Coagulation Factor IX (Recombinant), pegylated) for the...